Cyduct Diagnostics Inc
CYduct Diagnostics, Inc., a healthcare company, develops, produces, and markets medical devices for the assessment, identification, diagnosis and treatment of breast cancer. The company offers HALO system, a noninvasive device that utilizes proprietary technology to obtain breast fluid; and MammoView, a fiberoptic technology with the ability to view and collect cells and other abnormalities. It a… Read more
Cyduct Diagnostics Inc (CYDX) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 0.001x
Based on the latest financial reports, Cyduct Diagnostics Inc (CYDX) has a cash flow conversion efficiency ratio of 0.001x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.57K) by net assets ($-2.81 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cyduct Diagnostics Inc - Cash Flow Conversion Efficiency Trend (2016–2025)
This chart illustrates how Cyduct Diagnostics Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Cyduct Diagnostics Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Cyduct Diagnostics Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
INEP3F
SA:INEP3F
|
N/A |
|
Real American Capita
PINK:RLAB
|
N/A |
|
The Container Store Group, Inc.
PINK:TCSG
|
0.096x |
|
Access Engineering PLC
CM:AELN0000
|
N/A |
|
RNEW3F
SA:RNEW3F
|
N/A |
|
CONSORCIO ARA (4GJ.SG)
STU:4GJ
|
0.001x |
|
METALLURGICAL -H-
MU:6MT
|
N/A |
|
Kingland Property Corporation Ltd.
TWO:6264
|
N/A |
Annual Cash Flow Conversion Efficiency for Cyduct Diagnostics Inc (2016–2025)
The table below shows the annual cash flow conversion efficiency of Cyduct Diagnostics Inc from 2016 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | $-2.81 Million | $-71.98K | 0.026x | -64.89% |
| 2024-06-30 | $-2.40 Million | $-174.83K | 0.073x | -44.65% |
| 2023-06-30 | $-2.02 Million | $-266.85K | 0.132x | +60.11% |
| 2022-06-30 | $-1.55 Million | $-127.73K | 0.082x | +60.66% |
| 2021-06-30 | $-1.13 Million | $-57.95K | 0.051x | +216.33% |
| 2020-06-30 | $-752.64K | $-12.20K | 0.016x | +84.64% |
| 2019-06-30 | $-1.31 Million | $-11.54K | 0.009x | +448.27% |
| 2018-06-30 | $-3.18 Million | $8.02K | -0.003x | -111.64% |
| 2017-06-30 | $-2.71 Million | $-58.61K | 0.022x | +512.75% |
| 2016-06-30 | $-1.45 Million | $7.62K | -0.005x | -- |